Los Angeles officials launch online post-wildfire health dashboard
Offering a visual overview of monitoring locations across L.A. County, the dashboard – part of the Los Angeles County Post-Fire Air, Soil and Water Assessment Plan – was developed in collaboration with regional and state partners, LACDPH said in a media release issued Wednesday.
The technology offers users a visual overview of monitoring locations, including places where assessments are being conducted to measure four key metrics:
Air: Evaluation of indoor and outdoor air quality to detect pollutants that may affect respiratory health
Surface: Testing for contaminants on indoor surfaces, soil, coastal sand and wildfire debris to determine exposure risks
Water: Sampling of coastal waters, freshwater sources and pools to monitor for wildfire-related contaminations
Human health: Voluntary blood lead testing to determine potential exposure, particularly for children and other vulnerable individuals
'This dashboard is part of Los Angeles County's commitment to transparency, public engagement and community well-being,' LACDPH officials said in Wednesday's media release. 'By making this information accessible, the department aims to empower residents with timely, science-based insights into potential environmental health impacts of the recent wildfires.'
The data collected and shared through the dashboard will continue to inform long-term recovery efforts and guide health recommendations; however, officials noted that the technology currently does not have data for all locations, such as paths from mobile monitoring units.
That information will be added to the new dashboard once it is available, Public Health said.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
2 hours ago
- Washington Post
Got the sniffles? Here's what to know about summer colds and the COVID-19 variant called stratus
Summer heat, outdoor fun ... and cold and flu symptoms ? The three may not go together in many people's minds: partly owing to common myths about germs and partly because many viruses really do have lower activity levels in the summer.
Medscape
3 hours ago
- Medscape
Over A Third of US Adults Are Unaware of HPV
TOPLINE: Human papillomavirus (HPV) awareness remained critically low across the US between 2017 and 2020, with over one third of adults unaware of HPV and its corresponding vaccine. This was particularly true in Midwestern and Southern states, regions in which HPV-associated cancers are rising, and vaccination rates are suboptimal. METHODOLOGY: About 48,000 HPV-associated cancers are diagnosed annually in the US, predominantly in Midwestern and Southern states. Public awareness of HPV and its vaccine is crucial for increasing vaccination rates and preventing these cancers. Using data from the 2017-2020 Health Information National Trends Survey (HINTS) 5 Cycles 1-4 and 2022 HINTS Cycle 6 in the US, researchers assessed the awareness of HPV, HPV vaccine, and its role in causing cervical and oral cancers among 22,344 respondents (mean age, 49 years; 51.1% women). Participants responded to questions such as 'Have you ever heard of HPV?' and 'Before today, have you ever heard of the cervical cancer vaccine or HPV shot?' Those who had heard of HPV were asked, 'Do you think HPV can cause oral cancer?' and 'Do you think HPV can cause cervical cancer?' A response of 'no' or 'not sure' indicated lack of awareness about HPV. TAKEAWAY: Overall, 34.3% of adults lacked awareness about HPV, whereas 37.6% were unaware of the HPV vaccine. Among those aware of HPV, 70.8% did not know HPV causes oral cancer, whereas 28.3% were unaware of its link to cervical cancer. More than 60% of individuals in 45 states and Washington, DC, were unaware that HPV causes oral cancer, whereas unawareness of its link to cervical cancer varied widely (6.9%-57.4%). Awareness about HPV was lacking in over 40% of adults in seven states, predominantly from the Midwest and the South. Likewise, awareness about HPV vaccine was lacking in more than 40% of adults in 13 states, with nine being from the Midwest and the South. IN PRACTICE: 'In conclusion, given the importance of timely HPV vaccination and the risk of early-life exposure, there is a critical need to enhance HPV awareness among adolescents, young adults, parents or caregivers, and pediatric and adult healthcare professionals,' the authors of the study wrote. SOURCE: This study, led by Ashvita Garg, PhD, MPH, MBBS, Medical University of South Carolina in Charleston, South Carolina, was published online in JAMA Oncology. LIMITATIONS: The cross-sectional nature of the data prevented causal inferences, while the ecological nature of the analyses and limited sample sizes for certain states affected the generalizability of findings. DISCLOSURES: The research was supported by grants from the National Institute on Minority Health and Health Disparities, the National Library of Medicine, and the National Cancer Institute. One author disclosed receiving personal fees from Merck, grants and nonfinancial support from Stryker, and serving as deputy editor for JAMA Otolaryngology-Head & Neck Surgery. Another author reported receiving personal fees from Value Analytics Labs, outside the submitted work. No other disclosures were reported. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Medscape
3 hours ago
- Medscape
Surge in Chikungunya Cases Among UK Travellers
Travel-associated chikungunya cases in England have almost tripled this year, according to the UK Health Security Agency (UKHSA). Between January and June 2025, 73 cases were reported compared with 27 in the same period in 2024 – the highest number recorded for this timeframe. The majority were linked to travel to Sri Lanka, India, and Mauritius, where local outbreaks are ongoing. Most of the reported cases were in London. For the first time, cases of Oropouche virus were also confirmed in UK travellers. All were linked to travel to Brazil. Other Travel-Associated Infections The UKHSA report — Travel-Associated Infections in England, Wales and Northern Ireland: January to June 2025— also found: Cholera: Eight cases reported, compared with one in 2024. Most had travelled to India and Ethiopia, with all Ethiopia-linked cases tied to an outbreak there. Meningococcal disease (MenW): Cases linked to travel to Saudi Arabia for Umrah and Hajj, and to household contacts of returning travellers. Dengue: Cases fell by 67% to 161, compared with 490 last year. Zika virus: Four cases reported, down from nine in 2024. Chikungunya Outbreaks Widen Chikungunya is a mosquito-borne viral infection found mainly in Africa and Asia, with cases also reported in parts of Europe and North America. This year, large outbreaks have been seen in the Americas and Asia, with notable surges in China and on the Indian Ocean islands of Réunion, Mayotte, and Mauritius. 'We're seeing a worrying increase in cases among travellers returning to the UK,' said Dr Philip Veal, consultant in public health at UKHSA. He described chikungunya as a 'nasty' disease that, while rarely fatal, can cause severe joint and muscle pain, headaches, sensitivity to light, and skin rashes. Symptoms usually resolve within weeks, but joint pain can persist for months or years. Up to 12% of patients still experience discomfort 3 years after infection. UKHSA stressed that the mosquitoes which transmit chikungunya are not established in the UK due to the climate, so there is currently no risk of local transmission. The agency said there is 'no risk of onward transmission of chikungunya in the UK'. Oropouche Virus on the Rise Oropouche virus is spread mainly by midge bites. Since 2024, infections have increased across South America, Central America, and the Caribbean, with Brazil seeing the largest outbreaks. The species of midge responsible for transmission in the Americas is not found in the UK or Europe. The disease often starts suddenly, with fever, chills, headache, joint pain, and muscle aches. Symptoms typically last up to 7 days, though in some cases it can cause meningitis or encephalitis. The UKHSA has advised pregnant travellers to take particular care due to recent concerns about infection during pregnancy. Preventative Measures "It is essential to take precautions against mosquito bites when travelling,' said Veal. Measures include using insect repellent, covering exposed skin, and sleeping under insecticide-treated nets. Travellers to high-risk areas may also consider vaccination. Two chikungunya vaccines have recently been approved for UK use, based on Joint Committee on Vaccination and Immunisation advice. They are available privately through travel clinics after assessment by a healthcare professional. The UKHSA also reminded travellers to Saudi Arabia for pilgrimage to ensure they are vaccinated with the MenACWY vaccine before departure.
